198 related articles for article (PubMed ID: 22669166)
1. Influence of δ-opioid receptors in the behavioral effects of nicotine.
Berrendero F; Plaza-Zabala A; Galeote L; Flores Á; Bura SA; Kieffer BL; Maldonado R
Neuropsychopharmacology; 2012 Sep; 37(10):2332-44. PubMed ID: 22669166
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of nicotine-induced rewarding effects in A2A knockout mice.
Castañé A; Soria G; Ledent C; Maldonado R; Valverde O
Neuropharmacology; 2006 Sep; 51(3):631-40. PubMed ID: 16793068
[TBL] [Abstract][Full Text] [Related]
3. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.
Berrendero F; Mendizábal V; Robledo P; Galeote L; Bilkei-Gorzo A; Zimmer A; Maldonado R
J Neurosci; 2005 Feb; 25(5):1103-12. PubMed ID: 15689546
[TBL] [Abstract][Full Text] [Related]
4. Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.
Castañé A; Valjent E; Ledent C; Parmentier M; Maldonado R; Valverde O
Neuropharmacology; 2002 Oct; 43(5):857-67. PubMed ID: 12384171
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice.
Berrendero F; Kieffer BL; Maldonado R
J Neurosci; 2002 Dec; 22(24):10935-40. PubMed ID: 12486188
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Balerio GN; Aso E; Maldonado R
Psychopharmacology (Berl); 2005 Sep; 181(2):260-9. PubMed ID: 15778877
[TBL] [Abstract][Full Text] [Related]
7. Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine.
Heidbreder C; Shoaib M; Shippenberg TS
Eur J Pharmacol; 1996 Mar; 298(3):207-16. PubMed ID: 8846818
[TBL] [Abstract][Full Text] [Related]
8. Mu-opioid receptors are involved in the tolerance to nicotine antinociception.
Galeote L; Kieffer BL; Maldonado R; Berrendero F
J Neurochem; 2006 Apr; 97(2):416-23. PubMed ID: 16539669
[TBL] [Abstract][Full Text] [Related]
9. Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.
Besson M; David V; Baudonnat M; Cazala P; Guilloux JP; Reperant C; Cloez-Tayarani I; Changeux JP; Gardier AM; Granon S
Psychopharmacology (Berl); 2012 Mar; 220(1):1-14. PubMed ID: 21901321
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice.
Jerlhag E; Engel JA
Drug Alcohol Depend; 2011 Sep; 117(2-3):126-31. PubMed ID: 21310553
[TBL] [Abstract][Full Text] [Related]
11. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.
Jackson KJ; Marks MJ; Vann RE; Chen X; Gamage TF; Warner JA; Damaj MI
J Pharmacol Exp Ther; 2010 Jul; 334(1):137-46. PubMed ID: 20400469
[TBL] [Abstract][Full Text] [Related]
12. Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice.
Galeote L; Berrendero F; Bura SA; Zimmer A; Maldonado R
Int J Neuropsychopharmacol; 2009 Jun; 12(5):615-25. PubMed ID: 18937881
[TBL] [Abstract][Full Text] [Related]
13. Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.
Trigo JM; Zimmer A; Maldonado R
Neuropharmacology; 2009 Jun; 56(8):1147-53. PubMed ID: 19376143
[TBL] [Abstract][Full Text] [Related]
14. The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.
Ignatowska-Jankowska BM; Muldoon PP; Lichtman AH; Damaj MI
Psychopharmacology (Berl); 2013 Oct; 229(4):591-601. PubMed ID: 23652588
[TBL] [Abstract][Full Text] [Related]
15. Nicotine-induced molecular alterations are modulated by GABA
Varani AP; Pedrón VT; Aon AJ; Höcht C; Acosta GB; Bettler B; Balerio GN
Addict Biol; 2018 Jan; 23(1):230-246. PubMed ID: 28419642
[TBL] [Abstract][Full Text] [Related]
16. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
[TBL] [Abstract][Full Text] [Related]
17. Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.
Valjent E; Mitchell JM; Besson MJ; Caboche J; Maldonado R
Br J Pharmacol; 2002 Jan; 135(2):564-78. PubMed ID: 11815392
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception.
Campbell VC; Taylor RE; Tizabi Y
Alcohol Clin Exp Res; 2007 Aug; 31(8):1435-40. PubMed ID: 17550364
[TBL] [Abstract][Full Text] [Related]
19. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
20. Nicotine withdrawal hyperalgesia and opioid-mediated analgesia depend on nicotine receptors in nucleus accumbens.
Schmidt BL; Tambeli CH; Gear RW; Levine JD
Neuroscience; 2001; 106(1):129-36. PubMed ID: 11564423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
